Celularity Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Celularity Inc. (CELU) on September 14, 2026, reporting events that occurred on September 11, 2026. The company is incorporated in Delaware and its Class A Common Stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance.
Material Changes and Regulatory Status
- Regained Compliance: Celularity received written notification from Nasdaq confirming it has regained compliance with the minimum bid price requirement (Listing Rule 5550(a)(2)) and the minimum market value of listed securities requirement (Listing Rule 5550(b)(2)).
- Closed Matters: Nasdaq has advised that the matters regarding bid price and market value are now closed.
- Outstanding Deficiency: The company remains non-compliant with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of periodic reports with the SEC. Management stated they are continuing to work to complete these filings.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. The primary risk disclosed is the continued delinquency in periodic SEC filings, which poses a threat to the company's continued listing on Nasdaq until resolved.
Investor Verification Checklist
- Verify the current status of Celularity's delayed periodic SEC filings (e.g., 10-K, 10-Q) to assess the risk of delisting.
- Confirm the current trading price and market capitalization to ensure continued compliance with Nasdaq rules.
- Review subsequent filings to determine if the outstanding reporting deficiency has been resolved.